Sciences Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viridian Therapeutics (NASDAQ:VRDN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Volatility & Risk Viridian Therapeutics has a beta of 1.13, […]

Exact Sciences (NASDAQ:EXAS – Get Rating) and Genetron (NASDAQ:GTH – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Institutional and Insider Ownership 94.5% of Exact Sciences shares are held […]

PotNetwork (OTCMKTS:POTN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings and target […]

Analysts expect that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will post sales of $461.86 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Exact Sciences’ earnings, with estimates ranging from $458.10 million to $466.90 million. Exact Sciences reported sales of $402.08 million during the same quarter last year, […]

Analysts expect Exact Sciences Co. (NASDAQ:EXAS – Get Rating) to announce ($1.12) earnings per share for the current quarter, according to Zacks. Seven analysts have issued estimates for Exact Sciences’ earnings, with the highest EPS estimate coming in at ($0.98) and the lowest estimate coming in at ($1.22). Exact Sciences posted earnings of ($0.18) per […]